Yes, you will be working with a medical professional the entire time
PIONEER 3 PIONEER 3 was a 78-week, multinational, randomized, double-blind trial that compared the long-term efficacy, safety, and tolerability of oral semaglutide 3, 7, or 14 mg with the dipeptidyl peptidase-4 inhibitor, sitagliptin, in 1864 patients (including 207 patients from Japan) with type 2 diabetes uncontrolled on metformin with or without a sulfonylurea [47]
It felt like my nose had been upgraded to a super-sensitive detector, and not in a good way
Understanding your specific formulation, its concentration, and the pharmacy assigned BUD gives you the foundation for proper storage decisions
Diab 130 , 358367 (2022)